NCT00115479View on ClinicalTrials.gov

KULeuven Intensive Insulin Therapy Study in Medical Intensive Care Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

1,200

Participants

Timeline

Start Date

March 31, 2002

Study Completion Date

June 30, 2005

Conditions

Critical Illness

Interventions

DRUG

intensive insulin therapy to maintain normoglycemia

Trial Locations (1)

B-3000

Catholic University of Leuven, University Hospital Gasthuisberg, Leuven

Sponsors

Collaborators (1)

Novo Nordisk A/S

All Listed Sponsors

collaborator

Fund for Scientific Research, Flanders, Belgium

OTHER

collaborator

Novo Nordisk A/S

INDUSTRY

lead

KU Leuven

OTHER

NCT00115479 - KULeuven Intensive Insulin Therapy Study in Medical Intensive Care Patients | Biotech Hunter | Biotech Hunter